Discontinued — last reported Q3 '24
Johnson & Johnson Accrued Compensation decreased by 1.3% to $6.93B in Q3 2025 compared to the prior quarter. Year-over-year, this metric grew by 1.1%, from $6.85B to $6.93B. Over 3 years (FY 2021 to FY 2024), Accrued Compensation shows a downward trend with a -26.0% CAGR.
Significant fluctuations often correlate with seasonal bonus payouts or changes in headcount and compensation structures.
The liability for earned but unpaid employee wages, bonuses, commissions, and benefits at the end of the reporting perio...
Standard across all industries, though sensitive to the specific compensation structure of the company.
accrued_compensation| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $10.51B | $10.37B | $10.17B | $3.59B | $8.74B | $8.55B | $3.33B | $6.67B | $5.69B | $3.99B | $7.02B | $6.92B | $6.85B | $4.13B | $7.05B | $7.02B | $6.93B |
| QoQ Change | — | -1.4% | -1.9% | -64.7% | +143.7% | -2.1% | -61.1% | +100.3% | -14.7% | -29.8% | +75.8% | -1.4% | -1.0% | -39.8% | +70.8% | -0.4% | -1.3% |
| YoY Change | — | — | — | — | -16.9% | -17.5% | -67.3% | -23.7% | -33.5% | +20.0% | — | +3.8% | +20.5% | +3.3% | +0.4% | +1.5% | +1.1% |
We use cookies for analytics. See our Privacy and Cookie Policy.